Vertex Pharmaceuticals stock price target raised to $150 from $120 at Barclays Related posts: Brett Arends’s ROI: 25 things I wish I knew when I graduated from high school Lockheed Martin upgraded to buy from neutral at Sterne Agee CRT S&P 500 up 0.3% at 1,887 Ocado shares rally 11% on reports of Amazon bid interest Post navigation Alexion Pharmaceuticals stock price target cut to $205 from $220 at Barclays USD/CAD edges higher as oil falls
